Full-Time

Specialist Software Engineer

Visualization

Posted on 7/2/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

In Person

Category
Web Development
Software Engineering
Required Skills
Power BI
Python
React.js
Data Science
R
SQL
Tableau
Data Analysis
Requirements
  • Expertise in visualization tools such as Tableau, Power BI, or React js equivalent.
  • Proficiency in SQL, Python, R, or other data analysis programming languages.
  • Strong understanding of medical data models, including Field Medical, Medinfo, and SciComm frameworks.
  • Excellent communication and stakeholder management skills.
  • Strong project management skills, with experience leading cross-functional teams.
  • Doctorate degree / Master's degree / Bachelor's degree and 8 to 13 years of Information Systems experience.
Responsibilities
  • Lead the design, development, and deployment of advanced data visualization solutions for Global Medical teams, enabling actionable insights across diverse business capabilities.
  • Develop interactive dashboards and analytical reports using industry-standard tools (e.g., Tableau, Power BI) to visualize complex medical data for various stakeholders, ensuring clarity and accuracy.
  • Develop visualization prototypes for building interactive applications using latest frameworks like React js.
  • Drive innovation in data visualization by introducing advanced techniques (e.g., predictive analytics, dynamic storytelling) to highlight trends and opportunities.
  • Monitor and enhance the performance of visualization tools, ensuring optimal load times and usability.
  • Ensure data integrity, quality, and compliance with regulatory standards, such as HIPAA and GDPR.
  • Oversee the implementation of automated data validation frameworks, ensuring consistency across datasets and reducing errors.
  • Partner with cross-functional teams to understand business requirements and translate them into scalable visualization solutions.
  • Present data insights and visualization solutions to senior leadership, enabling data-driven decision-making across the organization.
  • Train and mentor team members and business users on the effective use of visualization tools and analytics best practices.
  • Manage and mentor a team of data visualization experts and analysts, fostering a culture of collaboration and innovation.
  • Establish and monitor KPIs for the visualization team to ensure alignment with business goals and objectives.
  • Drive cross-functional collaboration with engineering, data science, and business teams to streamline workflows and enhance efficiency.
  • Drive the implementation of reusable, scalable frameworks for visualization solutions to support global reporting needs.
  • Support ad-hoc and strategic reporting requests with customized data visualizations tailored to business needs.
Desired Qualifications
  • Bachelor’s or Master’s degree in Data Science, Computer Science, Analytics, Business Administration, or a related field.
  • 7+ years of experience in data analytics, visualization, or business intelligence, preferably within the pharmaceutical, life sciences, or healthcare industry.
  • Demonstrated experience in managing global data projects and collaborating with cross-functional teams in a matrixed organization.
  • Advanced certifications in data visualization tools (e.g., Tableau Certified Professional, Microsoft Power BI Certification).
  • Familiarity with cloud platforms such as AWS, Azure, or GCP, and experience in integrating data visualization solutions with cloud-based architectures.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.